These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9208591)

  • 1. [CuZn-SOD determination of sera in patients with rheumatic diseases].
    Yu M; Shi L; Zhang C; Cheng R; Dong Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Feb; 18(1):66-9. PubMed ID: 9208591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
    Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunocytochemical study of CuZn superoxide dismutase in the myocardium of normal subjects and patients of rheumatic heart disease].
    Zheng Y
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):225-8, 255. PubMed ID: 1327452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An investigation on changes in blood CuZn-superoxide dismutase contents in type I, II schizophrenics].
    Wang H
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):6-8, 60. PubMed ID: 1591962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
    Li W; Cen Y; Wang H; Chen W; Liu D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
    Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
    Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CuZn-SOD and MDA in the serum and EPS of chronic prostatitis patients: quantitative determination and analysis].
    Hou SC; Ai XB; Gao JG; Zhu H; Sun XQ
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):1012-5. PubMed ID: 21218645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
    Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
    J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
    Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
    Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pro- and antioxidant blood system in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Vipartene D; Iasiulevichute L; Butkene B; Valiukene K; Keturkene A; Redaĭtene E
    Ter Arkh; 2006; 78(6):10-4. PubMed ID: 16881356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum extracellular superoxide dismutase in pediatric patients with various diseases as judged by an ELISA.
    Ookawara T; Matsuura N; Oh-ishi T; Okazaki M; Kizaki T; Suzuki K; Hitomi Y; Suzuki K; Ohno H
    Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):291-6. PubMed ID: 11484883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
    Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The activity of superoxide dismutase and its isoenzymes in the immunocompetent cells of the peripheral blood in systemic lupus erythematosus and rheumatoid arthritis].
    Matveĭkov GP; Kaliia ES; Levin VI; San'ko NM
    Ter Arkh; 1994; 66(4):57-61. PubMed ID: 8016733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity.
    Ugur M; Yildirim K; Kiziltunc A; Erdal A; Karatay S; Senel K
    Scand J Rheumatol; 2004; 33(4):239-43. PubMed ID: 15370719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic changes in serum CuZn-containing superoxide dismutase in patients with lung cancer].
    Zhou D; Tian YP; He ZQ
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):421-2, 445. PubMed ID: 2556249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.